Foundation Medicine to collaborate with Bristol Myers Squibb on companion diagnostic for...

cafead

Administrator
Staff member
  • cafead   Apr 11, 2023 at 07:42: PM
via Molecular profiling company Foundation Medicine on Tuesday announced a collaboration with Bristol Myers Squibbto develop the FoundationOne CDx test as a companion diagnostic to repotrectinib, Bristol Myers Squibb’s investigational tyrosine kinase inhibitor (TKI).

article source